• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性血液透析患者血清脂质异常的患病率

Prevalence of serum lipid abnormalities in chronic hemodialysis.

作者信息

Brunzell J D, Albers J J, Haas L B, Goldberg A P, Agadoa L, Sherrard D J

出版信息

Metabolism. 1977 Aug;26(8):903-10. doi: 10.1016/0026-0495(77)90009-9.

DOI:10.1016/0026-0495(77)90009-9
PMID:195181
Abstract

Fasting levels of serum triglyceride, cholesterol, high-density lipoprotein (HDL), apoprotein A-I, HDL cholesterol, and HDL triglyceride were measured in 94 uremic males receiving maintenance hemodialysis and 6 uremic males receiving chronic peritoneal dialysis. These patients had higher serum triglyceride levels (p less than 0.001) and lower cholesterol levels (p less than 0.001) than normal controls. The dialysis patients treated with androgen or propranolol and those who were hypothyroid or diabetic had significantly higher triglyceride levels than the other dialysis subjects. The dialysis patients who had no additional secondary causes of hypertriglyceridemia had abnormalities in HDL; in comparison to normals and triglyceride-matched controls, these patients had elevated HDL triglyceride levels and low HDL cholesterol levels, despite similar HDL apoprotein A-I levels. The HDL cholesterol levels appeared to be lower in those patients than could be accounted for by their degree of hypertriglyceridemia.

摘要

对94名接受维持性血液透析的男性尿毒症患者和6名接受慢性腹膜透析的男性尿毒症患者测定了血清甘油三酯、胆固醇、高密度脂蛋白(HDL)、载脂蛋白A-I、HDL胆固醇和HDL甘油三酯的空腹水平。这些患者的血清甘油三酯水平高于正常对照组(p<0.001),胆固醇水平低于正常对照组(p<0.001)。接受雄激素或普萘洛尔治疗的透析患者以及甲状腺功能减退或糖尿病患者的甘油三酯水平明显高于其他透析患者。没有其他继发性高甘油三酯血症病因的透析患者HDL存在异常;与正常人和甘油三酯匹配的对照组相比,这些患者的HDL甘油三酯水平升高,HDL胆固醇水平降低,尽管HDL载脂蛋白A-I水平相似。这些患者的HDL胆固醇水平似乎低于其高甘油三酯血症程度所能解释的水平。

相似文献

1
Prevalence of serum lipid abnormalities in chronic hemodialysis.慢性血液透析患者血清脂质异常的患病率
Metabolism. 1977 Aug;26(8):903-10. doi: 10.1016/0026-0495(77)90009-9.
2
Atherogenic lipoprotein changes in the absence of hyperlipidemia in patients with chronic renal failure treated by hemodialysis.接受血液透析治疗的慢性肾衰竭患者在无高脂血症情况下的致动脉粥样硬化脂蛋白变化。
Atherosclerosis. 1997 Jun;131(2):229-36. doi: 10.1016/s0021-9150(97)00054-3.
3
Apoprotein A and apoprotein B in patients with chronic renal failure undergoing hemodialysis and in renal graft recipients.接受血液透析的慢性肾衰竭患者及肾移植受者的载脂蛋白A和载脂蛋白B
Nephron. 1983;35(3):171-4. doi: 10.1159/000183069.
4
Plasma lipid profile and coronary artery disease in Brazilian hemodialysis patients.
Int J Cardiol. 1995 Feb;48(2):163-6. doi: 10.1016/0167-5273(94)02224-7.
5
Lipoprotein heterogeneity in end-stage renal disease.终末期肾病中的脂蛋白异质性。
Kidney Int. 1993 Feb;43(2):410-8. doi: 10.1038/ki.1993.60.
6
Nonfasting non-high-density lipoprotein cholesterol is adequate for lipid management in hemodialysis patients.非空腹非高密度脂蛋白胆固醇适用于血液透析患者的血脂管理。
Am J Kidney Dis. 2005 Jun;45(6):1067-72. doi: 10.1053/j.ajkd.2005.03.002.
7
Impaired metabolism of high density lipoprotein in uremic patients.尿毒症患者高密度脂蛋白代谢受损。
Kidney Int. 1992 Jun;41(6):1653-61. doi: 10.1038/ki.1992.238.
8
Lipoprotein abnormalities in hyperlipidemic and normolipidemic men on hemodialysis with chronic renal failure.慢性肾衰竭血液透析的高脂血症和血脂正常男性的脂蛋白异常
Kidney Int. 1992 May;41(5):1394-9. doi: 10.1038/ki.1992.204.
9
Lipid profiles and lipase activities in children and adolescents with chronic renal failure treated conservatively or with hemodialysis or transplantation.接受保守治疗、血液透析或移植治疗的慢性肾衰竭儿童及青少年的血脂谱和脂肪酶活性。
Pediatr Res. 1984 Aug;18(8):783-8. doi: 10.1203/00006450-198408000-00025.
10
Serum lipid metabolism abnormalities and change in lipoprotein contents in patients with advanced-stage renal disease.晚期肾病患者的血清脂质代谢异常及脂蛋白含量变化
Clin Chim Acta. 2001 Dec;314(1-2):27-37. doi: 10.1016/s0009-8981(01)00681-7.

引用本文的文献

1
A Cluster of Proteins Implicated in Kidney Disease Is Increased in High-Density Lipoprotein Isolated from Hemodialysis Subjects.从血液透析患者分离出的高密度脂蛋白中,与肾脏疾病相关的一组蛋白质增加。
J Proteome Res. 2015 Jul 2;14(7):2792-806. doi: 10.1021/acs.jproteome.5b00060. Epub 2015 Jun 15.
2
Biochemical markers of vascular calcification in elderly hemodialysis patients.老年血液透析患者血管钙化的生化标志物。
Mol Cell Biochem. 2013 Feb;374(1-2):21-7. doi: 10.1007/s11010-012-1500-y. Epub 2012 Nov 3.
3
Treatment of chronic hemodialysis patients with low-dose fenofibrate effectively reduces plasma lipids and affects plasma redox status.
低剂量非诺贝特治疗慢性血液透析患者能有效降低血脂,并影响血浆氧化还原状态。
Lipids Health Dis. 2012 Jul 6;11:47. doi: 10.1186/1476-511X-11-47.
4
Lipid profiles and oxidative stress parameters in male and female hemodialysis patients.男性和女性血液透析患者的血脂谱和氧化应激参数。
Mol Cell Biochem. 2011 Jul;353(1-2):59-63. doi: 10.1007/s11010-011-0774-9. Epub 2011 Mar 9.
5
Absorption and excretion of colestilan in healthy subjects.健康受试者中考来烯胺的吸收与排泄。
Clin Pharmacokinet. 2010;49(1):47-52. doi: 10.2165/11318120-000000000-00000.
6
Central and peripheral adaptations to physical training in patients with end-stage renal disease.终末期肾病患者对体育锻炼的中枢和外周适应性
Sports Med. 2001;31(9):651-65. doi: 10.2165/00007256-200131090-00002.
7
[The apolipoproteins in man ].[人类中的载脂蛋白]
Klin Wochenschr. 1982 Jul 1;60(13):673-49. doi: 10.1007/BF01716796.
8
[Alterations of fat metabolism in renal disease - pathogenetic mechanisms (author's transl)].肾脏疾病中脂肪代谢的改变 - 发病机制(作者译)
Klin Wochenschr. 1982 Apr 1;60(7):327-36. doi: 10.1007/BF01721622.
9
Plasma cholesterol metabolism in end-stage renal disease. Difference between treatment by hemodialysis or peritoneal dialysis.终末期肾病中的血浆胆固醇代谢。血液透析或腹膜透析治疗的差异。
J Clin Invest. 1986 Apr;77(4):1071-83. doi: 10.1172/JCI112406.
10
The effects of diuretics and adrenergic-blocking agents on plasma lipids.利尿剂和肾上腺素能阻滞剂对血浆脂质的影响。
West J Med. 1986 Aug;145(2):210-8.